Medicines labeled for the same conditions
Alternatives to bempedoic acid
9 other medicines are given the same way (oral) and in the same FDA class as bempedoic acid or labeled mainly for the same use (heart attack and coronary artery disease); the others include 5 HMG-CoA reductase inhibitors, 1 peroxisome proliferator receptor alpha agonist and 1 dietary cholesterol absorption inhibitor (FDA labels read October 8, 2026).
Which medicines are labeled for the same conditions as bempedoic acid?
Heart attack and coronary artery disease lists all 38 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.
| Medicine and FDA class | Shared indication | Generic labelers (oral) | Pharmacy cost | Boxed warning | Shortage |
|---|---|---|---|---|---|
| Bempedoic acidadenosine triphosphate-citrate lyase inhibitor | this medicine | none listed | $13.81 per tablet 180 mg tablet | No | No current entry |
| AtorvastatinHMG-CoA reductase inhibitor | Heart attack and coronary artery disease, High cholesterol | 61 labelers | $0.0228 per tablet 10 mg tablet | No | No current entry |
| RosuvastatinHMG-CoA reductase inhibitor | Heart attack and coronary artery disease, High cholesterol | 46 labelers | $0.0692 per tablet 40 mg tablet | No | No current entry |
| PravastatinHMG-CoA reductase inhibitor | Heart attack and coronary artery disease, High cholesterol | 37 labelers | $0.058 per tablet 20 mg tablet | No | No current entry |
| SimvastatinHMG-CoA reductase inhibitor | Heart attack and coronary artery disease, High cholesterol | 27 labelers | $0.0321 per tablet 20 mg tablet | No | No current entry |
| LovastatinHMG-CoA reductase inhibitor | Heart attack and coronary artery disease, High cholesterol | 19 labelers | $0.0436 per tablet 20 mg tablet | No | No current entry |
| Gemfibrozilperoxisome proliferator receptor alpha agonist | Heart attack and coronary artery disease, High cholesterol | 27 labelers | $0.104 per tablet 600 mg tablet | Yes | A presentation being discontinued |
| Ezetimibe and simvastatindietary cholesterol absorption inhibitor | Heart attack and coronary artery disease, High cholesterol | 7 labelers | $0.285 per unit 10-80 mg | No | No current entry |
| Niacinnicotinic acid | Heart attack and coronary artery disease, High cholesterol | 13 labelers | $0.193 per tablet 500 mg tablet | No | No current entry |
| Canagliflozinsodium-glucose cotransporter 2 inhibitor | Heart attack and coronary artery disease | none listed | $19.13 per tablet 100 mg tablet | No | No current entry |
Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)
What do pharmacies pay for each?
The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What next?
- Bempedoic acid: the full record
- label, generics, price, shortages, recalls